Rabbit anti estrone antibody recognizes the aromatized C18 steroid, estrone. Less than 0.01% cross reactivity was observed with estradiol-17B, estriol, progesterone and testosterone.
In humans estrone is produced mainly by the ovaries, placenta and also adipose tissue of men and post menopausal women.
- Target Species
- Product Form
- Serum - liquid
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
- 0.09% Sodium Azide (NaN3)
- Synthetic estrone conjugated to Bovine Serum Albumin.
- Store at +4oC or at -20oC if preferred.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
- 18 months from date of despatch.
- For research purposes only
This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Applications of Estrone antibody
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using the appropriate negative/positive controls.
Copyright © 2020 Bio-Rad Antibodies (formerly AbD Serotec)
Secondary Antibodies Available
Product Specific References
References for Estrone antibody
Karabchevsky, A. et al. (2013) Study of Immobilization Procedure on Silver Nanolayers and Detection of Estrone with Diverged Beam Surface Plasmon Resonance (SPR) Imaging
Biosensors 3: 157-170
Karabchevsky, A. et al. (2011) Optical immunosensor for endocrine disruptor nanolayer detection by surface plasmon resonance imaging
Proc. SPIE 8099, Biosensing and Nanomedicine IV, 809918